Uric Acid and Acute Kidney Injury in the Critically Ill

Rationale & Objective: Uric acid is excreted by the kidney and accumulates in acute kidney injury (AKI). Whether higher plasma uric acid level predisposes to AKI or its complications is not known. Study Design: Prospective observational cohort study. Setting & Participants: 2 independent coh...

Full description

Bibliographic Details
Main Authors: Anand Srivastava, Ragnar Palsson, David E. Leaf, Angelica Higuera, Margaret E. Chen, Polly Palacios, Rebecca M. Baron, Venkata Sabbisetti, Andrew N. Hoofnagle, Sucheta M. Vaingankar, Paul M. Palevsky, Sushrut S. Waikar
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:Kidney Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S259005951930010X
_version_ 1818132974346960896
author Anand Srivastava
Ragnar Palsson
David E. Leaf
Angelica Higuera
Margaret E. Chen
Polly Palacios
Rebecca M. Baron
Venkata Sabbisetti
Andrew N. Hoofnagle
Sucheta M. Vaingankar
Paul M. Palevsky
Sushrut S. Waikar
author_facet Anand Srivastava
Ragnar Palsson
David E. Leaf
Angelica Higuera
Margaret E. Chen
Polly Palacios
Rebecca M. Baron
Venkata Sabbisetti
Andrew N. Hoofnagle
Sucheta M. Vaingankar
Paul M. Palevsky
Sushrut S. Waikar
author_sort Anand Srivastava
collection DOAJ
description Rationale & Objective: Uric acid is excreted by the kidney and accumulates in acute kidney injury (AKI). Whether higher plasma uric acid level predisposes to AKI or its complications is not known. Study Design: Prospective observational cohort study. Setting & Participants: 2 independent cohorts of critically ill patients: (1) 208 patients without AKI admitted to the intensive care unit (ICU) at Brigham & Women’s Hospital between October 2008 and December 2016; and (2) 250 participants with AKI requiring renal replacement therapy (RRT) who had not yet initiated RRT enrolled in the Acute Renal Failure Trial Network (ATN) Study. Exposure: Plasma uric acid level upon ICU admission and before RRT initiation in the ICU and ATN Study cohorts, respectively. Outcomes: Incident AKI and 60-day mortality in the ICU and ATN Study cohorts, respectively. Analytical Approach: Logistic regression models were used to test the association of plasma uric acid level with incident AKI and 60-day mortality. Results: In the ICU cohort, median plasma uric acid level was 4.7 (interquartile range [IQR], 3.6-6.4) mg/dL, and 40 patients (19.2%) developed AKI. Higher plasma uric acid levels associated with incident AKI, but this association was confounded by serum creatinine level and was not significant after multivariable adjustment (adjusted OR per doubling of uric acid, 1.50; 95% CI, 0.80-2.81). In the ATN Study cohort, median plasma uric acid level was 11.1 (IQR, 8.6–14.2) mg/dL, and 125 participants (50.0%) died within 60 days. There was no statistically significant association between plasma uric acid levels and 60-day mortality in either unadjusted models or after multivariable adjustment for demographic, severity-of-illness, and kidney-specific covariates (adjusted OR per doubling of uric acid, 1.15; 95% CI, 0.71-1.86). Limitations: Heterogeneity of ICU patients. Conclusions: Plasma uric acid levels upon ICU admission or before RRT initiation are not independently associated with adverse clinical outcomes in critically ill patients. Index Words: AKI, ICU, uric acid, RRT, dialysis
first_indexed 2024-12-11T08:45:21Z
format Article
id doaj.art-8c6ac62c596d4f51b6505888f5293ae1
institution Directory Open Access Journal
issn 2590-0595
language English
last_indexed 2024-12-11T08:45:21Z
publishDate 2019-01-01
publisher Elsevier
record_format Article
series Kidney Medicine
spelling doaj.art-8c6ac62c596d4f51b6505888f5293ae12022-12-22T01:14:09ZengElsevierKidney Medicine2590-05952019-01-01112130Uric Acid and Acute Kidney Injury in the Critically IllAnand Srivastava0Ragnar Palsson1David E. Leaf2Angelica Higuera3Margaret E. Chen4Polly Palacios5Rebecca M. Baron6Venkata Sabbisetti7Andrew N. Hoofnagle8Sucheta M. Vaingankar9Paul M. Palevsky10Sushrut S. Waikar11Division of Nephrology and Hypertension, Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; Division of Renal Medicine, Brigham and Women’s Hospital, Boston, MA; Address for Correspondence: Anand Srivastava, MD, MPH, Center for Translational Metabolism and Health, Institute for Public Health and Medicin, Division of Nephrology and Hypertension, Northwestern University Feinberg School of Medicine, 633 N St. Clair St, Ste 18-083, Chicago, IL 60611.Division of Renal Medicine, Brigham and Women’s Hospital, Boston, MADivision of Renal Medicine, Brigham and Women’s Hospital, Boston, MADivision of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, MADivision of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, MADivision of Renal Medicine, Brigham and Women’s Hospital, Boston, MADivision of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, MADivision of Renal Medicine, Brigham and Women’s Hospital, Boston, MADepartment of Laboratory Medicine, University of Washington, Seattle, WADepartment of Medicine, University of California at San Diego, La Jolla, CARenal Section, Veterans Affairs Pittsburgh Healthcare System and Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PADivision of Renal Medicine, Brigham and Women’s Hospital, Boston, MARationale & Objective: Uric acid is excreted by the kidney and accumulates in acute kidney injury (AKI). Whether higher plasma uric acid level predisposes to AKI or its complications is not known. Study Design: Prospective observational cohort study. Setting & Participants: 2 independent cohorts of critically ill patients: (1) 208 patients without AKI admitted to the intensive care unit (ICU) at Brigham & Women’s Hospital between October 2008 and December 2016; and (2) 250 participants with AKI requiring renal replacement therapy (RRT) who had not yet initiated RRT enrolled in the Acute Renal Failure Trial Network (ATN) Study. Exposure: Plasma uric acid level upon ICU admission and before RRT initiation in the ICU and ATN Study cohorts, respectively. Outcomes: Incident AKI and 60-day mortality in the ICU and ATN Study cohorts, respectively. Analytical Approach: Logistic regression models were used to test the association of plasma uric acid level with incident AKI and 60-day mortality. Results: In the ICU cohort, median plasma uric acid level was 4.7 (interquartile range [IQR], 3.6-6.4) mg/dL, and 40 patients (19.2%) developed AKI. Higher plasma uric acid levels associated with incident AKI, but this association was confounded by serum creatinine level and was not significant after multivariable adjustment (adjusted OR per doubling of uric acid, 1.50; 95% CI, 0.80-2.81). In the ATN Study cohort, median plasma uric acid level was 11.1 (IQR, 8.6–14.2) mg/dL, and 125 participants (50.0%) died within 60 days. There was no statistically significant association between plasma uric acid levels and 60-day mortality in either unadjusted models or after multivariable adjustment for demographic, severity-of-illness, and kidney-specific covariates (adjusted OR per doubling of uric acid, 1.15; 95% CI, 0.71-1.86). Limitations: Heterogeneity of ICU patients. Conclusions: Plasma uric acid levels upon ICU admission or before RRT initiation are not independently associated with adverse clinical outcomes in critically ill patients. Index Words: AKI, ICU, uric acid, RRT, dialysishttp://www.sciencedirect.com/science/article/pii/S259005951930010X
spellingShingle Anand Srivastava
Ragnar Palsson
David E. Leaf
Angelica Higuera
Margaret E. Chen
Polly Palacios
Rebecca M. Baron
Venkata Sabbisetti
Andrew N. Hoofnagle
Sucheta M. Vaingankar
Paul M. Palevsky
Sushrut S. Waikar
Uric Acid and Acute Kidney Injury in the Critically Ill
Kidney Medicine
title Uric Acid and Acute Kidney Injury in the Critically Ill
title_full Uric Acid and Acute Kidney Injury in the Critically Ill
title_fullStr Uric Acid and Acute Kidney Injury in the Critically Ill
title_full_unstemmed Uric Acid and Acute Kidney Injury in the Critically Ill
title_short Uric Acid and Acute Kidney Injury in the Critically Ill
title_sort uric acid and acute kidney injury in the critically ill
url http://www.sciencedirect.com/science/article/pii/S259005951930010X
work_keys_str_mv AT anandsrivastava uricacidandacutekidneyinjuryinthecriticallyill
AT ragnarpalsson uricacidandacutekidneyinjuryinthecriticallyill
AT davideleaf uricacidandacutekidneyinjuryinthecriticallyill
AT angelicahiguera uricacidandacutekidneyinjuryinthecriticallyill
AT margaretechen uricacidandacutekidneyinjuryinthecriticallyill
AT pollypalacios uricacidandacutekidneyinjuryinthecriticallyill
AT rebeccambaron uricacidandacutekidneyinjuryinthecriticallyill
AT venkatasabbisetti uricacidandacutekidneyinjuryinthecriticallyill
AT andrewnhoofnagle uricacidandacutekidneyinjuryinthecriticallyill
AT suchetamvaingankar uricacidandacutekidneyinjuryinthecriticallyill
AT paulmpalevsky uricacidandacutekidneyinjuryinthecriticallyill
AT sushrutswaikar uricacidandacutekidneyinjuryinthecriticallyill